Explain the pathophysiology of hepatic encephalopathy and the therapeutic rationale for lactulose.

Prepare for Liver Disease and Tumors Test with tailored flashcards and questions. Get detailed explanations and improve your knowledge. Ace the medical student exam!

Multiple Choice

Explain the pathophysiology of hepatic encephalopathy and the therapeutic rationale for lactulose.

Hepatic encephalopathy arises when the failing liver cannot detoxify gut-derived nitrogenous waste, so ammonia produced by intestinal bacteria from dietary protein enters the bloodstream. Impaired hepatic urea cycle function and portosystemic shunting allow ammonia to reach the brain, where it crosses the blood–brain barrier and is taken up by astrocytes. There it is converted to glutamine, causing osmotic swelling of astrocytes and disrupted neurotransmission, which leads to the neuropsychiatric and motor symptoms of encephalopathy. Lactulose works by changing the colonic environment and reducing ammonia absorption. It is not absorbed in the small intestine; in the colon, it is fermented by bacteria to short-chain acids, acidifying the lumen. The lower pH keeps ammonia in its protonated form, ammonium (NH4+), which is less able to cross gut membranes, effectively trapping it in the gut and reducing systemic levels. The osmotic effect of lactulose also increases stool frequency and decreases intestinal transit time, further limiting ammonia production and absorption. Additionally, lactulose can shift the gut flora toward fewer urease-producing organisms, further decreasing ammonia generation. Bilirubin buildup is not the cause of hepatic encephalopathy, and lactulose does not neutralize bilirubin. The condition is not driven by increased ammonia production, and lactulose does not raise sodium or correct hyponatremia as its primary mechanism.

Hepatic encephalopathy arises when the failing liver cannot detoxify gut-derived nitrogenous waste, so ammonia produced by intestinal bacteria from dietary protein enters the bloodstream. Impaired hepatic urea cycle function and portosystemic shunting allow ammonia to reach the brain, where it crosses the blood–brain barrier and is taken up by astrocytes. There it is converted to glutamine, causing osmotic swelling of astrocytes and disrupted neurotransmission, which leads to the neuropsychiatric and motor symptoms of encephalopathy.

Lactulose works by changing the colonic environment and reducing ammonia absorption. It is not absorbed in the small intestine; in the colon, it is fermented by bacteria to short-chain acids, acidifying the lumen. The lower pH keeps ammonia in its protonated form, ammonium (NH4+), which is less able to cross gut membranes, effectively trapping it in the gut and reducing systemic levels. The osmotic effect of lactulose also increases stool frequency and decreases intestinal transit time, further limiting ammonia production and absorption. Additionally, lactulose can shift the gut flora toward fewer urease-producing organisms, further decreasing ammonia generation.

Bilirubin buildup is not the cause of hepatic encephalopathy, and lactulose does not neutralize bilirubin. The condition is not driven by increased ammonia production, and lactulose does not raise sodium or correct hyponatremia as its primary mechanism.

More practice questions